Menten AI

Business Services · Canada · 1-10 Employees

View Company Info for Free

Overview

Headquarters

2405-51 E Liberty St, Toronto, Ontario, ...

Revenue

<$5 Million

Industry

Business Services Software Testing Research & Development
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1

About Menten AI

Menten AI specializes in pioneering generative AI technology for peptide drug design, focusing on the development of peptide macrocycles for complex drug targets. Their platform, MAUD 1.0, is validated across the preclinical discovery pipeline and is trusted by top pharmaceutical companies for its high hit rate and ability to optimize drug-like peptides. The company aims to accelerate drug discovery by combining generative AI with physics-based models and quantum simulations. Menten AI's innovative approach is set to unlock the potential of peptides in creating life-changing medicines.Explore more
Menten AI's Social MediaPopular SearchesMenten AiMenten AI IncMentenMenten Biotechnology Labs IncSIC Code 87,873NAICS Code 54,541Show more

Menten AI Org Chart

PhoneEmail
SS
Canada flag for contact location.

Alliances Manager

PhoneEmail
SY
Canada flag for contact location.

Alliances Manager

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is Menten AI your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to Menten AI

Compare insights from companies similar to Menten AI, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

Menten AI

<$5M
1-10
Private
-
2018
SS
Simona ShimonovAlliances Manager
$8.7M
11-50
Private
$15M
2017
Tomas Babej, Co-Founder & Chief Technology Officer at ProteinQure
Tomas BabejCo-Founder & Chief Technology Officer
<$5M
11-50
Private
-
2004
JY
Jun YanCEO & President
<$5M
11-50
Private
$6M
2017
<$5M
1-10
Private
-
2017
RM
Robert MurgitaChief Scientific Director
<$5M
1-10
Private
-
2018
<$5M
1-10
Private
<$5M
2015
Illustration of an envelope

Company Profile Activity

i

Among all Business Services companies

Low Activity

High Activity

Activity Insights

Menten AI is experiencing very low activity levels compared to other companies in the Business Services sector.

What does this means?

Menten AI is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Menten AI.

Menten AI Tech Stack

Menten AI News & Media

  • Menten AI Announces Completion of Research Collaboration with Bristol Myers Squibb

    SAN FRANCISCO--(BUSINESS WIRE)-- #CADD--Menten AI, Inc., a biotechnology company with a generative AI platform for design and optimization of peptide macrocycles, today announced the completion of a previously undisclosed research collaboration and licensing agreement with Bristol Myers Squibb applying Menten AI’s platform for optimization of cyclic peptides. Menten AI’s platform combines state-of-the-art machine learning techniques with physics-based models and quantum chemistry simulations to
Read more news

Top Business Services Companies

Frequently Asked Questions Regarding Menten AI

What is Menten AI's official website?
Menten AI's official website is www.menten.ai
What is Menten AI's Revenue?
Menten AI's revenue is <$5 Million
What is Menten AI's SIC code?
Menten AI's SIC: 87,873
What is Menten AI's NAICS code?
Menten AI's NAICS: 54,541
How many employees does Menten AI have?
Menten AI has 1-10 employees
What industry does Menten AI belong to?
Menten AI is in the industry of: Business Services, Software Testing, Research & Development
What is Menten AI competition?
Menten AI top competitors include: ProteinQure, Phenomic AI, Remedium AI, Ranomics
What technology does Menten AI use?
Some of the popular technologies that Menten AI uses are: reCAPTCHA, Google Cloud Platform, HashiCorp Terraform, Python
What does Menten AI do?

Menten AI specializes in pioneering generative AI technology for peptide drug design, focusing on the development of peptide macrocycles for complex drug targets. Their platform, MAUD 1.0, is validated across the preclinical discovery pipeline and is trusted by top pharmaceutical companies for its high hit rate and ability to optimize drug-like pep... tides. The company aims to accelerate drug discovery by combining generative AI with physics-based models and quantum simulations. Menten AI's innovative approach is set to unlock the potential of peptides in creating life-changing medicines.Read More

What are Menten AI social media links?
Menten AI Linkedin page Menten AI Twitter page Menten AI Facebook page
Is Menten AI a public company?
Menten AI is private company therefore does not currently have an official ticker symbol
See more information about Menten AI

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.